Alcoholic and Non-Alcoholic Fatty Liver Disease

<p>1 Epidemiology and Risk Factors for Alcoholic Liver Disease<br>Mariana Lazo and Mack C. Mitchell</p><p>2 Global Epidemiology and Risk Factors for Non-Alcoholic Fatty Liver Disease<br>Abhijit Chowdhury and Zobair M. Younossi</p><p>3 Pathogenesis of Alcoholic Liver Disease<br>Gavin E. Arteel and David W. Crabb</p><p>4 Pathogenesis of NAFLD and NASH<br>Jacquelyn J. Maher</p><p>5 Animal Models of Alcoholic Liver Disease<br>Jun Xu and Hidekazu Tsukamoto</p><p>6 Animal Models of Nonalcoholic Fatty Liver Disease<br>Mariana Luisa Verdelho Moutinho Machado and Anna Mae Diehl</p><p>7 Genetic Basis of Alcoholic and Nonalcoholic Fatty Liver Disease<br>Silvia Sookoian and Carlos Jose Pirola</p><p>8 Clinical Features, Disease Modifiers and Natural History of Alcoholic Liver Disease<br>Luis S. Marsano, Vatsalya Vatsalya, Ammar Hassan, and Craig J. McClain</p><p>9 Nonalcoholic Fatty Liver Disease (NAFLD): Clinical Features, Disease Modifiers, and Natural History <br>Dawn M. Torres and Stephen A. Harrison </p><p>10 Diagnostic Approaches and Clinical Endpoints of Treatment in Alcoholic Liver Disease<br>Jaeyoun Cheong, Eva Stein, and Ramon Bataller</p><p>11 Diagnostic Considerations and Clinical Endpoints for Nonalcoholic Steatohepatitis<br>Arun J. Sanyal</p><p>12 Pathology of Alcoholic and Non-Alcoholic Fatty Liver Disease<br>Pierre Bedossa and David E. Kleiner</p><p>13 Hepatic and Extra-Hepatic Malignancies in Alcoholic Liver Disease<br>Samir Zakhari, Svetlana Radaeva, Vasilis Vasiliou</p><p>14 Hepatic and Extra-Hepatic Malignancies in NAFLD<br>Fabio Nascimbeni and Vlad Ratziu</p><p>15 Treatment of Alcoholic Liver Disease Including Emerging Therapies, Novel Targets and Liver Transplantation<br>Jan Petrasek and Gyongyi Szabo</p><p>16 Current and Emerging Therapies for Non-Alcoholic Fatty Liver Disease<br>Samer Gawrieh and Naga Chalasani</p><p>17 Nonalcoholic Fatty Liver Disease in Children<br/>Hannah I. Awai, Kimberly P. Newton, and Jeffrey B. Schwimmer<br></p>